Overview

A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy

Status:
Completed

Trial end date:
2004-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this clinical research study is to learn if BMS-247550 can shrink or slow the growth of the cancer in patients with non-small cell lung cancer who have failed first-line platinum based chemotherapy. The safety of this treatment will also be studied.

Phase:

Phase 2

Details

Lead Sponsor:

R-Pharm

Treatments:

Epothilones